Quick answers
- Is CVE-2026-108919 exploited in the wild?
- No. Junglewise Threat Intelligence has no report of CVE-2026-108919 being exploited in the wild.
- How severe is CVE-2026-108919?
- Medium severity, with a CVSS score of 4.3, published 12 October 2026.
- Which products and versions are affected?
- SourceCodester Drug Recommendation System 1.0.
- Is there a fix for CVE-2026-108919?
- No fixed version is recorded yet. Check the vendor's advisory in the references below. If you run it, Junglewise drafts a mitigation that fits your setup and applies it once you approve, with senior security engineers behind it.
- How is CVE-2026-108919 attacked?
- It is attacked over the network, in a web application.
- Am I affected by CVE-2026-108919?
- Check whether you run SourceCodester Drug Recommendation System at an affected version. Junglewise does that check for you around the clock: connect your code, cloud and domains, and it matches new vulnerabilities like this one against what you actually run and tells you when one reaches you.
Technical details
The vulnerability is a stored XSS flaw in the Student Registration component, specifically in the Auth/add_student.php file where user inputs (txtname, txtpassword, txtemail, txtphone, txtprevious_school) are not properly sanitized before being stored and displayed. An attacker can exploit this remotely by submitting malicious JavaScript through student registration fields, which is then executed in the browsers of users viewing the affected records. The attack requires no authentication and the exploit code is publicly available.
Affected products
- SourceCodester Drug Recommendation System 1.0
Timeline
- 2026-10-12: disclosed